1-3 of 3
Elisabeth van Pampus, MD, PhD
Close
Sort by
Journal Articles

Interim Analysis on a Dutch HOVON Multicenter Randomized Open Label Phase II Trial on 3 Rituximab Dosing Schemes In Chronic ITP Patients:

Jaap Jan Zwaginga, MD, PhD, Ronnie van der Holt, PhD, Bart J. Biemond, MD, PhD, Peter A.W. te Boekhorst, MD, PhD, Mark Levin, MD, PhD, Art Vreughdenhil, MD, PhD, P.C. Huijgens, MD, PhD, Anneke Brand, MD, PhD, Rene van der Griend, MD, PhD, Marleen Luten, Hans Pruijt, MD, PhD, Okke de Weerdt, Elisabeth van Pampus, MD, PhD, Sonja Zweegman, MD, PhD, Rene Hollestein, Harry R. Koene, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2514.
https://doi.org/10.1182/blood.V116.21.2514.2514
Published: 2010
Journal Articles

Shedding of Procoagulant Microparticles from Platelets through Integrin Outside-In Signaling Involving WASP and the Actin Cytoskeleton.

Sandra Cauwenberghs, Marion A.H. Feijge, Alan G.H. Harper, Stewart O. Sage, PhD, Elisabeth van Pampus, MD, PhD, Joyce Curvers, PhD, Johan W.M. Heemskerk, PhD
Journal: Blood
Blood (2006) 108 (11): 1529.
https://doi.org/10.1182/blood.V108.11.1529.1529
Published: 2006
Journal Articles

Assessment of the Clinical Benefit of Prophylactic Platelet Transfusion in Thrombocytopenia Using Novel Methodology To Measure Thrombus Formation and Thrombin Generation.

Sandra Cauwenberghs, Marion A.H. Feijge, Johan W.M. Heemskerk, PhD, Elisabeth van Pampus, MD, PhD, Joyce Curvers, PhD
Journal: Blood
Blood (2006) 108 (11): 949.
https://doi.org/10.1182/blood.V108.11.949.949
Published: 2006